PRIONLAR KELTIRIB CHIQARADIGAN KASALLIKLAR TAHLILI
Keywords:
prion, prion oqsillari, prion kasalliklari, sporatik, genetik, orttirilgan, asab tizimi.Abstract
Ushbu adabiyotlar tahlilida oxirgi 10 yil ichida prionlar keltirib chiqargan kasalliklar tahlili haqida ma’lumotlar yoritilgan. Prion kasalliklari, prionlar deb ataladigan g'ayritabiiy shakldagi oqsillardan kelib chiqadigan kasalliklar guruhi: sporadik (Yakob-Kreytsfeldt kasalligi), genetik (irsiy Yakob-Kreytsfeldt kasalligi, Gerstmann Sträussler-Scheinker sindromi va halokatli oilaviy uyqusizlik), orttirilgan (kuru, variant Yakob-Kreytsfeldt kasalligi va yatrogen Yakob-Kreytsfeldt kasalligi) shakllar mavjud. Prionlar keltirib chiqargan kasalliklar kam uchraydi lekin kasallik og‘ir xolatlarda kechishi bilan axamiyatli hisoblanadi. Prion kasalligi odamlar asab tizimiga ta’sir qiluvchi sharoitlar guruhini ifodalaydi. Prion kasalliklari insonlarda Altsgeymer kasalligi, amyotrofik lateral skleroz, Parkinson kasalligi kabi bir qancha kasalliklarni keltirib chiqarishi mumkin deb hisoblanadi. Prion kasalliklarni o‘rganish usullari kam bo‘lganligi sababli bu kasallikni to‘liq o‘rganishda muommolar mavjud.
References
Appleby BS, Lyketsos CG. Rapidly progressive dementias and the treatment of human prion diseases. Expert Opin Pharmacother 2011;12:1-12
Bizzi, A.; Pascuzzo, R.; Blevins, J.; Grisoli, M.; Lodi, R.; Moscatelli, M.E.M.; Castelli, G.; Cohen, M.L.; Schonberger, L.B.; Foutz, A.; et al. Evaluation of a New Criterion for Detecting Prion Disease with Diffusion Magnetic Resonance Imaging. JAMA Neurol. 2020, 77, 1141–1149. [CrossRef]
Brandner S., Iseman S., Raeber A., et al. Normal host prion protein necessary for scrapie induced neurotoxicity. Nature 1996; 379:339 40.
Bruce M.E., Will R.G., Ironside J.W., McConnell J., et al. Transmissions to mice indicate that "new variant" Creutzfeldt Jacob disease is caused by the BSE agent. Nature 1997; 389:498 501.
Gençer, A.G.; Pelin, Z.; Küçükali, C.I.; Topçuo ˘glu, O.B.; Yilmaz, N. Creutzfeldt-Jakob disease. Psychogeriatrics 2011, 11, 119–124. [CrossRef]
Goldman JS, Vallabh SM. Genetic counseling for prion disease: updates and best practices. Genetics in Medicine. (2022) [In Press]: doi: 10.1016/j.gim.2022.06.003
Hill A.F., Zeidler M., Ironside J., Collinge J. Diagnosis of new variant Creutzfeldt–Jacob disease by tonsil biopsy. Lancet 1996; 347:921 5.
Imran M; Mahmood S. An overview of human prion diseases. Virol, J. 2011, 8, 559.
Korczyn A.D. Human prion diseases. Proceedings of 49th Annual meeting of American Academy of Neurology; 2017.Apr 12–19, Boston, MA. p. 1 19.
Lindholm PF, Annen K, Ramsey G. Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets 2011;11:45-56.
Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem 2011;305: 1-22.
Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genet Dev 2013;23:345-351.
Manix, M.; Kalakoti, P.; Henry, M.; Thakur, J.; Menger, R.; Guthikonda, B.; Nanda, A. Creutzfeldt-Jakob disease: Updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg. Focus 2015, 39, E2. [CrossRef]
Michael D, Geschwind. Continuum (Minneap Minn). 2015 December; 21; 1612-1638, doi: 10, 1212/CON 0000000000000251.
Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic CreutzfeldtJakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012;79:1499-1506.
Owen J, Beck J, Campbell T, Adamson G, Gorham M, Thompson A, et al. Predictive testing for inherited prion disease: report of 22 years experience. Eur J Hum Genet. (2014) 22:1351–6. doi: 10.1038/ejhg.2014.42
Palmer M.S., Collinge J. Prion diseases: an introduction. In: Collinge J., Palmer M.S., editors. Prion Diseases. Oxford: Oxford University Press; 2015.
Prusiner S.B. Human prion diseases and neurodegeneration: prions, prions, prions. Berlin. Heidelberg; 1998. p.1 17.
Prusiner S.B. Prions causing neurodegenerative diseases of humans and animals. In: Jolles G., Stutzmann J.M., editors. Neurodegenerative diseases. Acad Press; 1996. p.23 80.
Puopolo M, Ladogana A, Vetrugno V, Pocchiari M. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion. 2011;51:1556-1566.
Rudge, P.; Hyare, H.; Green, A.; Collinge, J.; Mead, S. Imaging and CSF analyses effectively distinguish CJD from its mimics. J. Neurol. Neurosurg. Psychiatry 2018, 89, 461–466. [CrossRef]
Sikorska B, Liberski PP. Human prion diseases: from kuru to variant Creutzfeldt-Jakob disease. Subcell Biochem 2012;65:457-496.
Sikorska, B.; Knight, R.; Ironside, J.W.; Liberski, P.P. Creutzfeldt-Jakob disease. Adv. Exp. Med. Biol. 2012, 724, 76–90.
Schwartz M, Brandel J-P, Babonneau ML, Boucher C, Schaerer E, Haik S, et al. Genetic testing in Prion disease: psychological consequences of the decisions to know or not to know. Front Genet. (2019) 10:895. doi: 10.3389/fgene.2019.00895
Uttley, L.; Carroll, C.; Wong, R.; Hilton, D.A.; Stevenson, M. Creutzfeldt-Jakob disease: A systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020, 20, e2–e10. [CrossRef]
Vacca, V.M., Jr. CJD: Understanding Creutzfeldt-Jakob disease. Nursing 2016, 46, 36–43. [CrossRef] [PubMed]
Chazot G., Brousolle E., Lapras CI., Blatter T., Aguzzi A., Kopp N. New variant of Creutzfeld–Jacob Disease in a 26 year old French man. Lancet 1996; 347:1181.
Wang LH, Bucelli RC, Patrick E, et al. Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol 2013;260:498-506.
Watson, N.; Brandel, J.P.; Green, A.; Hermann, P.; Ladogana, A.; Lindsay, T.; Mackenzie, J.; Pocchiari, M.; Smith, C.; Zerr, I.; et al. The importance of ongoing international surveillance for Creutzfeldt–Jakob disease. Nat. Rev. Neurol. 2021, 17, 362–379. [CrossRef]
Downloads
Published
How to Cite
Issue
Section
License
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo